HB 610 — expanding the definition of providers who can certify patients of the therapeutic cannabis program and relative to release of a defendant pending trial and relative to product labeling and information guide requirements for cannabis products and the prohibition of the sale of hemp products containing certain levels of THC.

HB 610 (Amendment #2023-2083s)

Amendment #2023-2083s text of HB 610.

The document summary and details above are public. The full text is available to signed-in accounts.